CURIS, INC. Debt Instrument, Increase, Accrued Interest
CURIS, INC. (CRIS) reported Debt Instrument, Increase, Accrued Interest of $1.59 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-02-24.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentIncreaseAccruedInterest · last filed 2015-02-24
- CURIS, INC. debt instrument, increase, accrued interest for the quarter ending 2014-12-31 was -$1.16M.
- CURIS, INC. debt instrument, increase, accrued interest for the quarter ending 2014-09-30 was $916.31K, a 434.05% increase year-over-year.
- CURIS, INC. debt instrument, increase, accrued interest for the quarter ending 2014-06-30 was $866.10K, a 251.74% increase year-over-year.
- CURIS, INC. debt instrument, increase, accrued interest for the quarter ending 2014-03-31 was $968.96K, a 188.53% increase year-over-year.
- CURIS, INC. debt instrument, increase, accrued interest for fiscal 2014 was $1.59M, a 110.60% increase from fiscal 2013.
- CURIS, INC. debt instrument, increase, accrued interest for fiscal 2013 was $753.64K.
| Period end | Debt Instrument, Increase, Accrued Interest 3 month | Debt Instrument, Increase, Accrued Interest 6 month | Debt Instrument, Increase, Accrued Interest 9 month | Debt Instrument, Increase, Accrued Interest 12 month |
|---|---|---|---|---|
| 2014-12-31 | -$1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | -$247.91K derived: sum of 2 quarters · filed 2015-02-24 | $618.19K derived: sum of 3 quarters · filed 2015-02-24 | $1.59M 10-K · filed 2015-02-24 |
| 2014-09-30 | $916.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $1.78M derived: sum of 2 quarters · filed 2014-11-10 | $2.75M 10-Q · filed 2014-11-10 | $2.75M derived: sum of 4 quarters · filed 2014-11-10 |
| 2014-06-30 | $866.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $1.84M 10-Q · filed 2014-08-07 | $1.84M derived: sum of 3 quarters · filed 2014-08-07 | $2.01M derived: sum of 4 quarters · filed 2014-08-07 |
| 2014-03-31 | $968.96K 10-Q · filed 2014-05-09 | $968.96K derived: sum of 2 quarters · filed 2014-05-09 | $1.14M derived: sum of 3 quarters · filed 2014-05-09 | $1.39M derived: sum of 4 quarters · filed 2014-05-09 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $171.58K derived: sum of 2 quarters · filed 2014-03-13 | $417.81K derived: sum of 3 quarters · filed 2014-03-13 | $753.64K 10-K · filed 2014-03-13 |
| 2013-09-30 | $171.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $417.81K derived: sum of 2 quarters · filed 2013-11-12 | $753.64K 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $246.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $582.06K 10-Q · filed 2013-08-08 | ||
| 2013-03-31 | $335.83K 10-Q · filed 2013-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |